Induction of a CD3+/CD56+ lymphocyte pop
β
Engel, Barbara C.; Laws, Hans-JΓΌrgen; Buttlies, Barbara; Kahn, Thomas; GΓΆbel, Ul
π
Article
π
1998
π
John Wiley and Sons
π
English
β 125 KB
Background. Adjuvant interleukin-2 (IL-2) therapy after stem cell transplantation can improve the prognosis of patients with Ewing tumors. This has been attributed to stimulation of the immune system and its antineoplastic activity, thus eliminating minimal residual disease. As the side effects of s